Riverwood Capital

Horizon Reclaim IPO Description – Founded in 2006, Horizon Reclaim manufactures reclaimed rubber products from recycled rubber waste such as used tyres, rubber tubes, tread peelings, and industrial rubber scrap. The company converts waste rubber into value-added products, including Natural Reclaim Rubber, Synthetic Reclaim Rubber (EPDM and Butyl), and crumb rubber, which are widely used across […]

Adon Agro IPO Description – Adon Agro operates in the agro-commodity trading and processing sector, focusing on dry fruits, nuts, seeds, and berries. Its portfolio includes almonds, walnuts, pistachios, raisins, dates, apricots, and allied products sourced from both domestic and international markets such as the UAE, Afghanistan, Chile, the USA, and Sri Lanka. The company sells

Devson Catalyst IPO Description – Devson Catalyst is an specialty chemicals manufacturer engaged in producing catalysts, adsorbents, and ceramic balls used in critical industrial processes across oil & gas, petrochemicals, steel, and fertilizer industries. The company has a manufacturing facility in Gujarat with an installed production capacity of 6,205 MT per annum. The company’s product portfolio

India Homes Rights Issue dates is not finalized. India Homes has undergone a strategic rebranding from its legacy as India Steel Works to emerge as a focused player in the Indian real estate sector. This evolution marks a decisive pivot from traditional steel manufacturing to high-value asset monetization. By leveraging its historic industrial land bank,

APPL Containers IPO Description – APPL Containers operates in the container manufacturing sector, focusing on the production of ISO-compliant shipping containers through its manufacturing facility located in Bhavnagar, Gujarat. The company’s manufacturing facility spans 59,115.09 square meters and has an installed capacity to produce up to 15,000 containers annually. Since its incorporation, the company has

Virupaksha Organics IPO Description – Virupaksha Organics is an R&D-driven Indian pharmaceutical manufacturer engaged in the production of active pharmaceutical ingredients (APIs) and intermediates, with an expanding CDMO business. As of 31 March 2025, it has a diversified portfolio of 54 products comprising 23 APIs and 31 intermediates across high-volume therapeutic segments such as anti-histamines,